Terms: = Skin cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Diagnosis
23 results:
1. A UVR-sensor wearable device intervention to reduce sun exposure in melanoma survivors: Results from a randomized controlled trial.
Vogel RI; Luo X; Brown K; Jewett P; Dona AC; Nagler RH; Ahmed RL; Martinson BC; Lazovich D
PLoS One; 2023; 18(2):e0281480. PubMed ID: 36763627
[TBL] [Abstract] [Full Text] [Related]
2. Occupational Sun Exposure Among Physical Education Teachers in Primary and Secondary Schools in Andalusia, Spain.
Barón DR; Sánchez NB; Ruiz FR; Martínez AR; Arjona JA; de Castro Maqueda G; Araujo IG; de Gálvez Aranda MV; Martínez AR; de Troya Martín M
J Cancer Educ; 2023 Aug; 38(4):1157-1162. PubMed ID: 36701024
[TBL] [Abstract] [Full Text] [Related]
3. TOX Outperforms foxp3, CD4 and GATA3 in Histopathological diagnosis of Early Mycosis Fungoides.
Ahmed MM; Hegazy AA; Embaby A; Nawwar EM; Hegazy SA; Ibrahim HM; Gobran MA
Turk Patoloji Derg; 2023; 39(1):15-22. PubMed ID: 35642346
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment.
Borcherding N; Severson KJ; Henderson N; Ortolan LS; Rosenthal AC; Bellizzi AM; Liu V; Link BK; Mangold AR; Jabbari A
Blood Adv; 2023 Feb; 7(3):321-335. PubMed ID: 35390145
[TBL] [Abstract] [Full Text] [Related]
5. Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes.
Gompertz-Mattar M; Perales J; Sahu A; Mondaca S; Gonzalez S; Uribe P; Navarrete-Dechent C
Arch Dermatol Res; 2022 Oct; 314(8):777-786. PubMed ID: 34647186
[TBL] [Abstract] [Full Text] [Related]
6. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract] [Full Text] [Related]
7. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.
Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ
Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Outcomes of Isolated Regional Lymph Node Recurrence in Patients With Malignant Cutaneous Melanoma.
Kwon J; Kim YA; Lee C; Kim BH; Kim S; Kim IH
Anticancer Res; 2019 Jun; 39(6):3147-3157. PubMed ID: 31177161
[TBL] [Abstract] [Full Text] [Related]
9. [Current possibilities of the differential diagnosis of plaque parapsoriasis and the early stages of mycosis fungoides].
Olisova OY; Grekova EV; Varshavsky VA; Gorenkova LG; Alekseeva EA; Zaletaev DV; Sydikov AA
Arkh Patol; 2019; 81(1):9-17. PubMed ID: 30830099
[TBL] [Abstract] [Full Text] [Related]
10. [Primary cutaneous localization revealing leukemia/T-cell lymphoma associated with chronic HTLV-1 infection in a adult. A case presentation].
Bentefouet TL; Boye A; Diousse P; Fall AS; Diop O; Gaulier A; Dieng MT; Touré A
Ann Pathol; 2019 Feb; 39(1):40-46. PubMed ID: 30578040
[TBL] [Abstract] [Full Text] [Related]
11. The risk of melanoma associated with ambient summer ultraviolet radiation.
Pinault L; Bushnik T; Fioletov V; Peters CE; King WD; Tjepkema M
Health Rep; 2017 May; 28(5):3-11. PubMed ID: 28513818
[TBL] [Abstract] [Full Text] [Related]
12. Histopathological aspects of cutaneous erythematous-papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma.
Perret RE; Josselin N; Knol AC; Khammari A; Cassecuel J; Peuvrel L; Dreno B;
Int J Dermatol; 2017 May; 56(5):527-533. PubMed ID: 28188628
[TBL] [Abstract] [Full Text] [Related]
13. The microenvironment in primary cutaneous melanoma with associated spontaneous tumor regression: evaluation for T-regulatory cells and the presence of an immunosuppressive microenvironment.
Gray A; Grushchak S; Mudaliar K; Kliethermes S; Carey K; Hutchens KA
Melanoma Res; 2017 Apr; 27(2):104-109. PubMed ID: 28125447
[TBL] [Abstract] [Full Text] [Related]
14. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.
Klemke CD; Booken N; Weiss C; Nicolay JP; Goerdt S; Felcht M; Géraud C; Kempf W; Assaf C; Ortonne N; Battistella M; Bagot M; Knobler R; Quaglino P; Arheiliger B; Santucci M; Jansen P; Vermeer MH; Willemze R
Br J Dermatol; 2015 Jul; 173(1):93-105. PubMed ID: 25864856
[TBL] [Abstract] [Full Text] [Related]
15. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.
Achberger S; Aldrich W; Tubbs R; Crabb JW; Singh AD; Triozzi PL
Mol Immunol; 2014 Apr; 58(2):182-6. PubMed ID: 24370793
[TBL] [Abstract] [Full Text] [Related]
16. Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells.
Tsaknakis B; Schaefer IM; Schwörer H; Sahlmann CO; Thoms KM; Blaschke M; Ramadori G; Cameron S
Med Oncol; 2014 Jan; 31(1):813. PubMed ID: 24338272
[TBL] [Abstract] [Full Text] [Related]
17. Adult T-cell leukemia/lymphoma accompanying follicular mucinosis: a case report with review of the literature.
Ishida M; Iwai M; Yoshida K; Kagotani A; Okabe H
Int J Clin Exp Pathol; 2013; 6(12):3014-8. PubMed ID: 24294393
[TBL] [Abstract] [Full Text] [Related]
18. Primary mucosal melanoma arising from the eustachian tube with CTLA-4, IL-17A, IL-17C, and IL-17E upregulation.
Wei C; Sirikanjanapong S; Lieberman S; Delacure M; Martiniuk F; Levis W; Wang BY
Ear Nose Throat J; 2013 Jan; 92(1):36-40. PubMed ID: 23354891
[TBL] [Abstract] [Full Text] [Related]
19. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
[TBL] [Abstract] [Full Text] [Related]
20. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
[TBL] [Abstract] [Full Text] [Related]
[Next]
